Stay updated on Tirzepatide in OSA: Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in OSA: Clinical Trial page.

Latest updates to the Tirzepatide in OSA: Clinical Trial page
- Check4 days agoChange DetectedNew citation added: Malhotra et al. Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of SURMOUNT-OSA (Nat Med 2026). The previous online-ahead-of-print citation was removed; revision: v3.5.0.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded related topics: Obstructive Sleep Apnea and MedlinePlus Genetics as metadata; to avoid alerts for minor changes, set an alert condition.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded a site revision label 'Revision: v3.4.2' and removed a government funding notice along with unrelated related-topic links (e.g., Obstructive Sleep Apnea, MedlinePlus Genetics) and a prior revision label; there are no changes to core study content, eligibility, outcomes, or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check47 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and NIH Clinical Center operating status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check54 days agoChange DetectedThe page now shows a glossary and updates UI labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with a Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in OSA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in OSA: Clinical Trial page.